StockData
Assembly Biosciences, Inc. logo

Assembly Biosciences, Inc. (ASMB) stock

ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)

Close on Nov 17, 2026Market cap $458.11MP/E –Yield –

Assembly Biosciences price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Assembly Biosciences's price to sales ratio was 5.9× on Nov 11, 2026, against 16.1× a year earlier. Over the last 5 years it ranged from 1.8× to 47.1×, with a median of 6.4×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.9×−8.5
2025Dec 31, 202514.5×+10.9
2024Dec 31, 20243.5×−10.0
2022Apr 29, 202213.5×+11.7
2021Apr 30, 20211.8×−0.6
2020Dec 31, 20202.4×−33.1
2019Dec 31, 201935.5×−4.6
2018Dec 31, 201840.0×–

More Assembly Biosciences figures

See a number that looks wrong?